 to the use of at least one compound of the invention and optionally one or more pharmaceutically compatible adjuvants for the production of a medicinal drug for vanilloid receptor 0-(VR0/TRPV0) regulation, preferably vanilloid receptor 0-(VR0/TRPV0) inhibition and/or vanilloid receptor 0-(VR0/TRPV0) stimulation. 